Paramyxovirus immunogens and related materials and methods
AssigneeOhio State Innovation Foundation
InventorsJianrong Li, Yu Zhang, Rongzhang Wang
Life of this patent
Estimating the term…
Abstract
The present invention includes methyltransferase (MTase)-defective recombinant viruses as live vaccine candidates for human metapneumovirus (hMPV), human respiratory syncytial virus (hRSV), and human parainfluenza virus type 3 (PIV3). Here the inventors provide the technical description for generating MTase-defective paramyxoviruses useful as immunogens, as well as related materials and methods.
Claims9
A recombinant paramyxovirus composition comprising a nucleic acid molecule which encodes large RNA polymerase (L) protein having a defective mRNA cap MTase domain in a paramyxovirus viral genome, wherein the paramyxovirus viral genome is human respiratory syncytial virus (hRSV);
- and,
- wherein the nucleic acid molecule which encodes large RNA polymerase (L) protein having a defective mRNA cap MTase domain carries at least one mutation in a S-adenosyl methionine (SAM) binding site;
- wherein the at least one mutation in the SAM binding site is in a G×G×G . . . D/E/W site in an amino acid sequence corresponding to amino acid positions 31-90 of SEQ ID NO:
- 3, wherein the mutations comprise:
- at position 31, A×G×G . . . D;
- at position 33, G×A×G . . . D;
- at position 35, G×G×A . . . D;
- and,
- at position 90, G×G×G . . . A.
An isolated live human respiratory syncytial virus (hRSV) rRSV-G1853A, as deposited with American Type Culture Collection (ATCC) under the Accession Number PTA-122916.
An isolated live human respiratory syncytial virus (hRSV) rRSV-G1857A, as deposited with American Type Culture Collection (ATCC) under the Accession Number PTA-122915.
Dependencies are inferred from the claim text.